Oxford Asset Management’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$74.9K	Buy	+27,330	New	+$86.5K	0.03%	424
2025 Q4	–	Sell	-46,270	Closed	-$123K	–	569
2025 Q3	$123K	Buy	+46,270	New	+$89.5K	0.04%	398
2024 Q3	–	Sell	-42,161	Closed	-$93.6K	–	348
2024 Q2	$93.6K	Buy	+42,161	New	+$99.2K	0.09%	242
2020 Q1	–	Sell	-17,182	Closed	-$1.02M	–	569
2019 Q4	$1.02M	Sell	17,182 -31,170	-64%	-$1.4M	0.03%	849
2019 Q3	$1.77M	Buy	48,352 +737	+2%	+$29.2K	0.04%	620
2019 Q2	$2.21M	Buy	+47,615	New	+$2.24M	0.05%	599
2019 Q1	–	Sell	-23,472	Closed	-$1.08M	–	1743
2018 Q4	$1.08M	Buy	23,472 +12,676	+117%	+$611K	0.03%	831
2018 Q3	$485K	Buy	+10,796	New	+$496K	0.01%	1321
2018 Q2	–	Sell	-11,046	Closed	-$799K	–	1762
2018 Q1	$799K	Buy	+11,046	New	+$811K	0.02%	1044
2017 Q4	–	Sell	-14,309	Closed	-$715K	–	1673
2017 Q3	$715K	Buy	+14,309	New	+$690K	0.01%	1083
2017 Q2	–	Sell	-25,211	Closed	-$890K	–	1530
2017 Q1	$890K	Sell	25,211 -4,440	-15%	-$102K	0.02%	854
2016 Q4	$371K	Sell	29,651 -36,290	-55%	-$432K	0.01%	633
2016 Q3	$913K	Sell	65,941 -171,002	-72%	-$1.94M	0.03%	532
2016 Q2	$2.34M	Sell	236,943 -43,399	-15%	-$719K	0.08%	338
2016 Q1	$4.74M	Buy	280,342 +125,265	+81%	+$2.02M	0.14%	172
2015 Q4	$3.53M	Buy	+155,077	New	+$3.91M	0.08%	269